XML 57 R47.htm IDEA: XBRL DOCUMENT v3.5.0.2
Related Party Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 16, 2016
Oct. 07, 2013
Mar. 24, 2012
Sep. 28, 2011
Mar. 24, 2010
May 31, 2015
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
May 31, 2016
Dec. 31, 2015
Aug. 01, 2015
May 31, 2014
Related-Party Transactions (Textual) [Abstract]                            
Long-term other assets             $ 1,326,317   $ 1,326,317     $ 676,803    
Subsidiary ownership percentage by parent               91.00%   91.00%       85.00%
Receivable from sale of intangible assets                     $ 1,000,000      
Future payments to be received from sale of intangible assets           $ 1,000,000                
Equity ownership percentage after transaction               20.00%   20.00%        
Maximum amount of additional equity fundraising               $ 10,000,000   $ 10,000,000        
Ownership of investment             16.90%   16.90%          
Carrying value of investment             $ 5,300,000   $ 5,300,000         $ 0
Available-for-sale Securities                            
Related-Party Transactions (Textual) [Abstract]                            
Investment owned (shares)             395,758   395,758          
Available-for-sale Securities | VGX International [Member]                            
Related-Party Transactions (Textual) [Abstract]                            
Investment owned (shares)                         465,364  
GeneOne Life Sciences [Member]                            
Related-Party Transactions (Textual) [Abstract]                            
Term   20 years                        
Payment received for license granted         $ 3,000,000                  
Deferred revenue from affiliated entity         $ 3,000,000                  
Period over which deferred revenue from affiliated entity will be recognized in years         8 years                  
Revenue from related parties             $ 463,000 113,000 $ 576,000 225,000        
Operating expenses related to affiliated entity             1,100,000 $ 5,300,000 1,300,000 $ 5,400,000        
Accounts receivable balance             345,000   345,000     4,000    
Accounts payable and accrued liability             424,000   424,000     165,000    
Long-term other assets             488,000   488,000     $ 373,000    
OncoSec [Member] | First warrant [Member]                            
Related-Party Transactions (Textual) [Abstract]                            
Common stock purchase warrant (in shares)       50,000                    
Term of the warrants in years       5 years                    
Exercise price of a five-year warrant ($ per share)       $ 24.00                    
OncoSec [Member] | Second warrant [Member]                            
Related-Party Transactions (Textual) [Abstract]                            
Common stock purchase warrant (in shares)     150,000                      
Term of the warrants in years     5 years                      
Exercise price of a five-year warrant ($ per share)     $ 20.00                      
Director [Member]                            
Related-Party Transactions (Textual) [Abstract]                            
Term 5 years                          
Operating expenses related to affiliated entity             $ 80,000   $ 80,000          
Expenses to reimburse $ 3,100,000